On May 23, 2024, MyMD Pharmaceuticals, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.96 USD | -5.77% |
|
+0.51% | -9.26% |
06-17 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
05-23 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.96 USD | -5.77% | +0.51% | 16.57M | ||
1.84 USD | +0.55% | -5.15% | 4.25M | ||
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.26% | 16.57M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- MyMD Pharmaceuticals, Inc. amended terms of the transaction